Skip to main content
Erschienen in: International Orthopaedics 10/2011

01.10.2011 | Original Paper

In vivo behaviour of low-temperature calcium-deficient hydroxyapatite: comparison with deproteinised bovine bone

verfasst von: Pavel Šponer, Marie Strnadová, Karel Urban

Erschienen in: International Orthopaedics | Ausgabe 10/2011

Einloggen, um Zugang zu erhalten

Abstract

This study aims to evaluate in detail the biological osteoconductive properties of the low-temperature synthetic porous calcium-deficient hydroxyapatite and to compare it with the biological apatite. Bone reactions to granules of similar sizes of the low-temperature hydroxyapatite and commercially available non-sintered deproteinized bovine bone were compared. Two different temperatures were used to fabricate two batches of newly developed porous hydroxyapatite with different carbonate groups content and specific surface area. The histological analysis of specimens with histomorphometry was performed at different time after in vivo implantation. Based on histological analysis, the level of bone formation in the spaces between the implanted granules and through the interconnected pores of all implanted materials within a cortical region (bone area ingrowth 72–85 %) was several-fold higher than within a cancellous bone site (bone area ingrowth 16–28 %) at three and six months after implantation. Within the cancellous bone site, bone coverage of the implanted material at six months was significantly higher in hydroxyapatite material fabricated using low-temperature synthesis and subsequent processing at 150°C than in hydroxyapatite scaffold developed using low-temperature synthesis with subsequent processing at 700°C or deproteinized bovine bone. According to our study, the bioactive properties of the low-temperature calcium-deficient hydroxyapatite are comparable with the biological apatite. The favourable influence of a high specific surface area of a low-temperature calcium-deficient hydroxyapatite on in vivo bone formation was emphasized.
Literatur
1.
Zurück zum Zitat Hirn M, de Silva U, Sidharthan S, Grimer RJ, Abudu A, Tillman RM, Carter SR (2009) Bone defects following curettage do not necessarily need augmentation. A retrospective study of 146 patients. Acta Orthop 80:4–8PubMedCrossRef Hirn M, de Silva U, Sidharthan S, Grimer RJ, Abudu A, Tillman RM, Carter SR (2009) Bone defects following curettage do not necessarily need augmentation. A retrospective study of 146 patients. Acta Orthop 80:4–8PubMedCrossRef
2.
Zurück zum Zitat Sponer P, Urban K, Urbanova E, Karpas K, Mathew PG (2009) Behavior of nonresorbable bioactive glass-ceramic implanted into long bone defects: comparison with cancellous allografts. Arch Orthop Trauma Surg 129:1353–1360PubMedCrossRef Sponer P, Urban K, Urbanova E, Karpas K, Mathew PG (2009) Behavior of nonresorbable bioactive glass-ceramic implanted into long bone defects: comparison with cancellous allografts. Arch Orthop Trauma Surg 129:1353–1360PubMedCrossRef
3.
Zurück zum Zitat Pecina M, Vukicevic S (2007) Biological aspects of bone, cartilage and tendon regeneration. Int Orthop 31:719–720PubMedCrossRef Pecina M, Vukicevic S (2007) Biological aspects of bone, cartilage and tendon regeneration. Int Orthop 31:719–720PubMedCrossRef
4.
Zurück zum Zitat McKay WF, Peckham SM, Badura JM (2007) A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE® Bone Graft). Int Orthop 31:729–734PubMedCrossRef McKay WF, Peckham SM, Badura JM (2007) A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE® Bone Graft). Int Orthop 31:729–734PubMedCrossRef
5.
Zurück zum Zitat White AP, Vaccaro AR, Hall JA, Whang PG, Friel BC, McKee MD (2007) Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal vision. Int Orthop 31:735–741PubMedCrossRef White AP, Vaccaro AR, Hall JA, Whang PG, Friel BC, McKee MD (2007) Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal vision. Int Orthop 31:735–741PubMedCrossRef
6.
Zurück zum Zitat Bishop GB, Einhorn TA (2007) Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 31:721–727PubMedCrossRef Bishop GB, Einhorn TA (2007) Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 31:721–727PubMedCrossRef
7.
Zurück zum Zitat Wopenka B, Pasteris JD (2005) A mineralogical perspective on the apatite in bone. Mater Sci Eng C Biomim Mater Sens Syst 25:131–143CrossRef Wopenka B, Pasteris JD (2005) A mineralogical perspective on the apatite in bone. Mater Sci Eng C Biomim Mater Sens Syst 25:131–143CrossRef
8.
Zurück zum Zitat Honig JF, Merten HA, Heinemann DE (1999) Risk of transmission of agents associated with Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Plast Reconstr Surg 103:1324–1325PubMedCrossRef Honig JF, Merten HA, Heinemann DE (1999) Risk of transmission of agents associated with Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Plast Reconstr Surg 103:1324–1325PubMedCrossRef
9.
Zurück zum Zitat Donath K, Breuner GA (1982) A method for the study of undecalcified bones and teeth with attached soft tissues—the sage-schliff (sawing and grinding) technique. J Oral Pathol 11:318–326PubMedCrossRef Donath K, Breuner GA (1982) A method for the study of undecalcified bones and teeth with attached soft tissues—the sage-schliff (sawing and grinding) technique. J Oral Pathol 11:318–326PubMedCrossRef
10.
11.
Zurück zum Zitat Wetzel AC, Stich H, Caffesse RG (1995) Bone apposition onto oral implants in the sinus area filled with different grafting materials. A histological study in beagle dogs. Clin Oral Implants Res 6:155–163PubMedCrossRef Wetzel AC, Stich H, Caffesse RG (1995) Bone apposition onto oral implants in the sinus area filled with different grafting materials. A histological study in beagle dogs. Clin Oral Implants Res 6:155–163PubMedCrossRef
12.
Zurück zum Zitat Hartl A, Bitzan P, Wanivenhaus A, Kotz R (2004) Faster integration of human allograft bone than of the bovine substitute Lubboc. Non-randomized evaluation of 20 cases with benign tumors or tumor-like conditions. Acta Orthop Scand 75:217–220PubMedCrossRef Hartl A, Bitzan P, Wanivenhaus A, Kotz R (2004) Faster integration of human allograft bone than of the bovine substitute Lubboc. Non-randomized evaluation of 20 cases with benign tumors or tumor-like conditions. Acta Orthop Scand 75:217–220PubMedCrossRef
13.
Zurück zum Zitat Briem D, Linhart W, Lehmann W, Meenen NM, Rueger JM (2002) Long-term results after application of a porous hydroxyapatite ceramic (Endobon) in proximal tibia fractures. Unfallchirurg 105:128–133PubMedCrossRef Briem D, Linhart W, Lehmann W, Meenen NM, Rueger JM (2002) Long-term results after application of a porous hydroxyapatite ceramic (Endobon) in proximal tibia fractures. Unfallchirurg 105:128–133PubMedCrossRef
14.
Zurück zum Zitat Meyer S, Floerkemeier T, Windhagen H (2008) Histological osseointegration of Tutobone®: First results in human. Arch Orthop Trauma Surg 128:539–544PubMedCrossRef Meyer S, Floerkemeier T, Windhagen H (2008) Histological osseointegration of Tutobone®: First results in human. Arch Orthop Trauma Surg 128:539–544PubMedCrossRef
15.
Zurück zum Zitat Traini T, Valentini P, Iezzi G, Piattelli A (2007) A histologic and histomorphometric evaluation of anorganic bovine bone retrieved 9 years after a sinus augmentation procedure. J Periodontol 78:955–961PubMedCrossRef Traini T, Valentini P, Iezzi G, Piattelli A (2007) A histologic and histomorphometric evaluation of anorganic bovine bone retrieved 9 years after a sinus augmentation procedure. J Periodontol 78:955–961PubMedCrossRef
16.
Zurück zum Zitat Ramaswamy Y, Haynes DR, Berger G et al (2005) Bioceramics composition modulate resorption of human osteoclasts. J Mater Sci Mater Med 16:1199–1205PubMedCrossRef Ramaswamy Y, Haynes DR, Berger G et al (2005) Bioceramics composition modulate resorption of human osteoclasts. J Mater Sci Mater Med 16:1199–1205PubMedCrossRef
17.
Zurück zum Zitat Flautre B, Descamps M, Delecourt C, Blary MC, Hardouin P (2001) Porous HA ceramic for bone replacement: role of the pores and interconnections—experimental study in the rabbit. J Mater Sci Mater Med 12:679–682PubMedCrossRef Flautre B, Descamps M, Delecourt C, Blary MC, Hardouin P (2001) Porous HA ceramic for bone replacement: role of the pores and interconnections—experimental study in the rabbit. J Mater Sci Mater Med 12:679–682PubMedCrossRef
18.
Zurück zum Zitat Itala AI, Ylanen HO, Ekholm C, Karlsson KH, Aro HT (2001) Pore diameter of more than 100 mm is not requisite for bone ingrowth in rabbits. J Biomed Mater Res 58:679–683PubMedCrossRef Itala AI, Ylanen HO, Ekholm C, Karlsson KH, Aro HT (2001) Pore diameter of more than 100 mm is not requisite for bone ingrowth in rabbits. J Biomed Mater Res 58:679–683PubMedCrossRef
19.
Zurück zum Zitat Pilliar RM, Filiaggi MJ, Wells JD, Grynpas MD, Kandel RA (2001) Porous calcium polyphosphate scaffolds for bone substitute applications—in vitro characterization. Biomaterials 22:963–972PubMedCrossRef Pilliar RM, Filiaggi MJ, Wells JD, Grynpas MD, Kandel RA (2001) Porous calcium polyphosphate scaffolds for bone substitute applications—in vitro characterization. Biomaterials 22:963–972PubMedCrossRef
20.
Zurück zum Zitat Tamai N, Myoui A, Tomita T, Nakase T, Tanaka J, Ochi T et al (2002) Novel hydroxyapatite ceramics with an interconnective porous structure exhibit superior osteoconduction in vivo. J Biomed Mater Res 59:110–117PubMedCrossRef Tamai N, Myoui A, Tomita T, Nakase T, Tanaka J, Ochi T et al (2002) Novel hydroxyapatite ceramics with an interconnective porous structure exhibit superior osteoconduction in vivo. J Biomed Mater Res 59:110–117PubMedCrossRef
21.
Zurück zum Zitat Kuroda T (1995) Bone formation and mechanical properties of the cancellous bone defect site filled with hydroxyapatite granules. Nippon Seikeigeka Gakkai Zasshi 69:1037–1049PubMed Kuroda T (1995) Bone formation and mechanical properties of the cancellous bone defect site filled with hydroxyapatite granules. Nippon Seikeigeka Gakkai Zasshi 69:1037–1049PubMed
22.
Zurück zum Zitat Lu JX, Gallur A, Flautre B, Anselme K, Deschamps M, Thierry B, Hardouin P (1998) Comparative study of tissue reactions to calcium phosphate ceramics among cancellous, cortical, and medullar bone sites in rabbits. J Biomed Mater Res 42:357–367PubMedCrossRef Lu JX, Gallur A, Flautre B, Anselme K, Deschamps M, Thierry B, Hardouin P (1998) Comparative study of tissue reactions to calcium phosphate ceramics among cancellous, cortical, and medullar bone sites in rabbits. J Biomed Mater Res 42:357–367PubMedCrossRef
23.
Zurück zum Zitat Hench LL (2000) Bioactive glasses and ceramics. In: Yamamuro T, Hench LL, Wilson J (eds) Handbook of bioactive ceramics. Boca Raton, CRC Press Hench LL (2000) Bioactive glasses and ceramics. In: Yamamuro T, Hench LL, Wilson J (eds) Handbook of bioactive ceramics. Boca Raton, CRC Press
24.
Zurück zum Zitat Afonso A, Santos JD, Vasconcelos M, Branco R, Cavalheiro J (1996) Granules of osteopatite and glass-reinforced hydroxyapatite implanted in rabbit tibiae. J Mater Sci Mater Med 7:507–510CrossRef Afonso A, Santos JD, Vasconcelos M, Branco R, Cavalheiro J (1996) Granules of osteopatite and glass-reinforced hydroxyapatite implanted in rabbit tibiae. J Mater Sci Mater Med 7:507–510CrossRef
25.
Zurück zum Zitat Bostrom MPG, Seigerman DA (2005) The clinical use of allografts, demineralized bone matrice, synthetic bone graft substitutes and osteoinductive growth factors: A survey study. HSS J 1:9–18PubMedCrossRef Bostrom MPG, Seigerman DA (2005) The clinical use of allografts, demineralized bone matrice, synthetic bone graft substitutes and osteoinductive growth factors: A survey study. HSS J 1:9–18PubMedCrossRef
26.
Zurück zum Zitat Ogose A, Hotta T, Kawashima H, Kondo N, Gu W, Kamura T, Endo N (2005) Comparison of hydroxyapatite and beta tricalcium phosphate as bone substitutes after excision of bone tumors. J Biomed Mater Res B Appl Biomater 72B:94–101CrossRef Ogose A, Hotta T, Kawashima H, Kondo N, Gu W, Kamura T, Endo N (2005) Comparison of hydroxyapatite and beta tricalcium phosphate as bone substitutes after excision of bone tumors. J Biomed Mater Res B Appl Biomater 72B:94–101CrossRef
27.
Zurück zum Zitat Schwarz C, Bornei CR (2005) Biphasic phospho-calcium ceramics used as bone substitutes are efficient in the management of severe acetabular bone loss in revision total hip arthroplasties. Eur J Orthop Surg Traumatol 15:191–196CrossRef Schwarz C, Bornei CR (2005) Biphasic phospho-calcium ceramics used as bone substitutes are efficient in the management of severe acetabular bone loss in revision total hip arthroplasties. Eur J Orthop Surg Traumatol 15:191–196CrossRef
28.
Zurück zum Zitat Mankani MH, Kuznetsov SA, Fowler B, Kingman A, Gehron Robey P (2001) In vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape. Biotechnol Bioeng 72:96–107PubMedCrossRef Mankani MH, Kuznetsov SA, Fowler B, Kingman A, Gehron Robey P (2001) In vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape. Biotechnol Bioeng 72:96–107PubMedCrossRef
29.
Zurück zum Zitat Cordonnier T, Layrolle P, Gaillard J, Langonne A, Sensebe L, Rosset P, Sohier J (2010) 3D environment on human mesenchymal stem cells differentiation for bone tissue engineering. J Mater Sci Mater Med 21:981–987PubMedCrossRef Cordonnier T, Layrolle P, Gaillard J, Langonne A, Sensebe L, Rosset P, Sohier J (2010) 3D environment on human mesenchymal stem cells differentiation for bone tissue engineering. J Mater Sci Mater Med 21:981–987PubMedCrossRef
30.
Zurück zum Zitat Kasten P, Beyen I, Niemeyer P, Luginbühl R, Bohner M, Richter W (2008) Porosity and pore size of β-tricalcium phosphate scaffold can influence protein production and osteogenic differentiation of human mesenchymal stem cells: An in vitro and in vivo study. Acta Biomater 4:1904–1915PubMedCrossRef Kasten P, Beyen I, Niemeyer P, Luginbühl R, Bohner M, Richter W (2008) Porosity and pore size of β-tricalcium phosphate scaffold can influence protein production and osteogenic differentiation of human mesenchymal stem cells: An in vitro and in vivo study. Acta Biomater 4:1904–1915PubMedCrossRef
31.
Zurück zum Zitat Kasten P, Vogel J, Luginbühl R, Niemeyer P, Tonak M, Lorenz H, Helbig L, Weiss S, Fellenberg J, Leo A, Simank HG, Richter W (2005) Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier. Biomaterials 26:5879–5889PubMedCrossRef Kasten P, Vogel J, Luginbühl R, Niemeyer P, Tonak M, Lorenz H, Helbig L, Weiss S, Fellenberg J, Leo A, Simank HG, Richter W (2005) Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier. Biomaterials 26:5879–5889PubMedCrossRef
Metadaten
Titel
In vivo behaviour of low-temperature calcium-deficient hydroxyapatite: comparison with deproteinised bovine bone
verfasst von
Pavel Šponer
Marie Strnadová
Karel Urban
Publikationsdatum
01.10.2011
Verlag
Springer-Verlag
Erschienen in
International Orthopaedics / Ausgabe 10/2011
Print ISSN: 0341-2695
Elektronische ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-010-1113-6

Weitere Artikel der Ausgabe 10/2011

International Orthopaedics 10/2011 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.